Key result
The molecular basis of primary ventricular arrhythmias, specifically long QT syndromes and Brugada syndrome, has recently been well characterized.
This review summarizes the molecular basis of primary ventricular arrhythmias, focusing on long QT and Brugada syndromes.
Updates molecular basis of LQTS and Brugada; leaves open translation to targeted therapies or risk stratification.
In this review, the up-to-date understanding of the molecular basis of primary ventricular arrhythmias will be outlined. Two disorders have recently been well described at the molecular level, the long QT syndromes and Brugada syndrome, and in this paper we review the current scientific knowledge of each disease.
No takes yet. Share an insight, caveat, or question.
Vatta et al. (2000) studied this question. The molecular basis of primary ventricular arrhythmias, specifically long QT syndromes and Brugada syndrome, has recently been well characterized.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: